Two GLP-1 pills are approved for weight loss in the US: the Wegovy pill from Novo Nordisk and Foundayo from Eli Lilly. A third pill, the Ozempic pill, has the same medicine as the Wegovy pill, but it is approved for type 2 diabetes, not weight loss. Here is how the three differ, what they cost as of November 2026, and how to get a prescription.
The short version
- The Wegovy pill and Foundayo are the only GLP-1 pills approved for weight loss.
- The Wegovy pill must be taken on an empty stomach with a 30-minute wait. Foundayo can be taken with or without food.
- If you pay cash through the maker's own pharmacy, both start at $149 a month and cost $299 a month at the highest doses.
- Supplements sold as "GLP-1" products are not GLP-1 medicines.
The GLP-1 pills you can get today
| Pill | Approved for | How you take it | Average weight loss in its main trial | Cash price |
|---|---|---|---|---|
| Wegovy pill (semaglutide), Novo Nordisk | Approved forWeight loss in adults. Also lowering the risk of heart attack, stroke and death from heart disease in adults who have heart disease and excess weight | How you take itOnce a day in the morning, on an empty stomach | Average weight loss in its main trial13.6% on the 25 mg dose after 64 weeks | Cash price$149 to $299 a month |
| Foundayo (orforglipron), Eli Lilly | Approved forWeight loss in adults | How you take itOnce a day, with or without food | Average weight loss in its main trial11.1% on the 17.2 mg dose after 72 weeks | Cash price$149 to $299 a month |
| Ozempic pill (semaglutide), Novo Nordisk | Approved forType 2 diabetes in adults. Not approved for weight loss | How you take itSame morning routine as the Wegovy pill | Average weight loss in its main trialNot tested as a weight-loss medicine | Cash priceDepends on the dose |
The weight-loss numbers come from each pill's FDA label. They include everyone who started the trial, even people who stopped taking the pill. On a placebo (a dummy pill), people lost 2.4% in the Wegovy pill trial and 2.1% in the Foundayo trial. The two pills were tested in different trials, with different people and different lengths, and never against each other. So treat the gap between 13.6% and 11.1% as a rough guide, not a ranking.
For comparison, the weekly shots did better in their own trials: about 15% for the 2.4 mg Wegovy shot and about 21% for the highest Zepbound dose. Based on those averages, a shot may suit you better if losing as much weight as possible matters most. But if needles have kept you away from treatment, a pill is now a real choice. Before December 2025, no GLP-1 pill was approved for weight loss.
The Wegovy pill
The FDA approved the Wegovy pill on December 22, 2025, and Novo Nordisk began selling it in early January 2026. It was the first GLP-1 pill approved for weight loss. It contains semaglutide, the same medicine as the Wegovy shot and Ozempic.
It is approved for adults with obesity, and for adults with overweight who also have at least one weight-related health problem, such as high blood pressure. Your prescriber decides whether you qualify, based on your weight, height and health history. You start at 1.5 mg for 30 days, then move to 4 mg, then 9 mg, a month at each step. The full dose is 25 mg.
The hard part is the routine. You take it in the morning on an empty stomach, with no more than 4 ounces of plain water. Then you wait at least 30 minutes before you eat, drink anything else or take other pills. The label's own data show your body absorbs more of the medicine when you use only a little water and wait longer before eating. Some people find this easy. Others, especially people who take several medicines each morning, find it a daily hassle. Our Wegovy pill vs injection guide can help you choose between the two forms.
Foundayo
Foundayo is Eli Lilly's daily weight-loss pill. The medicine in it is called orforglipron. The FDA approved it on April 1, 2026, for the same group of adults as the Wegovy pill. It is not approved for type 2 diabetes.
Its big advantage is simplicity. You swallow one tablet a day, with or without food, and the label sets no rules about water or waiting. You start at 0.8 mg. After at least 30 days you move to 2.5 mg, and after at least 30 more days to 5.5 mg. Your prescriber may raise it further, one step at a time, up to 17.2 mg.
One rule matters for some readers. If you take birth control pills, the label says to switch to a type of birth control you don't swallow, or add a barrier method such as condoms. Do this for 30 days after you start Foundayo and for 30 days after each dose increase. Our Foundayo guide has more detail.
The Ozempic pill and Rybelsus
Novo Nordisk began selling the Ozempic pill in the US in May 2026. It is a reformulated, renamed version of Rybelsus, the semaglutide tablet for type 2 diabetes. Its doses are different from Rybelsus doses, so one cannot be swapped for the other milligram for milligram. You take it with the same empty-stomach routine as the Wegovy pill.
It is approved for type 2 diabetes, not weight loss. A prescriber can still use it for weight loss, which is called "off-label" use. But insurance plans often won't pay for it that way. Some Ozempic pill doses have the same numbers as Wegovy pill doses (1.5, 4 and 9 mg), but they are separate products. Take only the one you were prescribed. Our Ozempic guide covers the diabetes side.
What GLP-1 pills cost
Paying cash
Both makers sell their pills through their own pharmacy services. You still need a prescription. These are the prices listed on each maker's website in November 2026:
- Wegovy pill, from NovoCare Pharmacy: $149 a month at 1.5 mg, $199 at 4 mg, and $299 at 9 mg and 25 mg. A month is one bottle of 30 tablets. (NovoCare)
- Foundayo, from LillyDirect: $149 a month at 0.8 mg and 2.5 mg, $199 at 5.5 mg, and $299 at 9 mg. The 2.5 mg and 5.5 mg prices are temporarily reduced through December 31, 2026. The 14.5 mg and 17.2 mg doses cost $299 a month only if you refill within 45 days. If you don't, Lilly's regular, higher price applies. (LillyDirect)
For comparison, NovoCare sells the standard Wegovy pens for $349 a month, so every dose of the pill costs less than that. New patients can get the two lowest pen doses for $199 a month for their first two months, through December 31, 2026. Both companies say they can change or cancel these prices at any time, so check the current price before you plan around it. Our weight loss injection cost guide lists the shot prices in one place.
With insurance
Coverage depends on your exact plan, not just your insurance company. Most large employers don't cover these medicines for weight loss. In KFF's 2026 survey of employers that offer health benefits, only 16% to 33% of companies with 200 or more workers covered GLP-1s for weight loss, depending on company size (KFF). Plans that do cover them usually want prior authorization first, which means your prescriber has to get the plan's approval before it pays.
If your plan covers the pill, both makers have savings programs that can bring your cost down to as little as $25 a month. These are only for people with commercial insurance, such as a plan through work. People on Medicare, Medicaid or other government plans can't use them.
Our guide to whether insurance covers GLP-1s lists what to ask your plan. If you are turned down, see what to do after a denial.
With Medicare
A temporary federal program called the Medicare GLP-1 Bridge runs from July 1, 2026 to December 31, 2027. It covers the Wegovy pill and Foundayo for weight loss for $50 a month, with prior authorization, for people who meet its weight and health rules. People with type 2 diabetes can't use the Bridge, but their regular Medicare drug plan may cover a GLP-1 for diabetes instead. One practical snag: NovoCare's home delivery service says it does not fill Bridge prescriptions right now, so you would use a different pharmacy. Our Medicare GLP-1 coverage guide explains who qualifies.
How to get a prescription for a GLP-1 pill
You have three main options: your own doctor, a local weight-loss clinic, or an online (telehealth) provider. Any of them will ask about your weight, height, health history and the medicines you already take.
Ask a specific question. Many clinics prescribe semaglutide, but that doesn't tell you whether they prescribe the pill or only the shot. Ask: "Do you prescribe the Wegovy pill or Foundayo, and which would you suggest for me?" If you plan to pay cash, also ask whether they can send the prescription to NovoCare Pharmacy or LillyDirect. Those are the pharmacies where the prices above apply.
Then the pharmacy takes over. NovoCare texts you to set up an account and pay, and orders usually ship within one business day after payment. LillyDirect has a pharmacy partner contact you to confirm details and any savings. Both deliver for free, and both let you pick up at a local pharmacy instead.
Our step-by-step prescription guide walks through the appointment. You can also compare online providers on our telehealth comparison page.
What isn't a GLP-1 pill
Search for GLP-1 pills and you'll find plenty of products that aren't the real medicine.
- Supplements sold as "GLP-1" or "GLP-1 support." These are not GLP-1 medicines, and no supplement is approved to treat obesity. The FDA does not approve supplements before they go on sale, so no one has checked that they work (FDA).
- Compounded semaglutide tablets or drops. Compounded means a pharmacy mixed its own version. These are not FDA approved, so the FDA has not checked them for safety, quality or how well they work. The FDA declared the semaglutide shortage over in February 2025. Since then, pharmacies generally may not make copies of the approved drug, with narrow exceptions. If someone offers you one, ask why it is allowed in your case and which licensed pharmacy makes it. Our compounded vs brand-name guide explains more.
- "Orforglipron" sold online without a prescription. The approved medicine is Foundayo, and it requires a prescription. A product sold online as orforglipron without one is not the approved medicine, and no one has checked what is in it.
Safety, in brief
Both weight-loss pills carry a boxed warning, the FDA's most serious kind of warning, about thyroid tumors. Medicines like these caused thyroid tumors in rats and mice. No one knows yet whether they do the same in people. Don't take either pill if you or a family member has had medullary thyroid cancer, or if you have a rare inherited condition called MEN 2.
The most common side effects are nausea, constipation, diarrhea and vomiting. They are often worst while the dose is being raised. If you have surgery or a procedure planned, tell your care team you take one of these pills. The labels warn that food or liquid can get into the lungs during anesthesia or deep sedation. Our side effects guide covers what is normal and when to call your doctor.
Which pill makes sense
If the morning routine sounds fine and you want the pill with the higher result in its own trial, ask about the Wegovy pill. If your mornings are busy, you take other medicines first thing, or you know you won't wait 30 minutes every day, Foundayo's simpler routine may matter more than a few points on paper. The cash prices are similar at most doses, so your coverage and your daily routine should probably decide it. Your prescriber can help you weigh that against your health history.
To find someone who prescribes these pills, search clinics by city or browse clinics by state. Then ask them the questions above before you book.
Sources
- Wegovy (semaglutide) injection and tablets: prescribing information, DailyMed (revised June 2026)
- Foundayo (orforglipron) tablets: prescribing information, DailyMed (revised July 2026)
- Rybelsus and Ozempic (semaglutide) tablets: prescribing information, DailyMed
- Novo Nordisk: FDA approves the Wegovy pill, December 22, 2025
- Eli Lilly: FDA approves Foundayo, April 1, 2026
- OASIS 4 trial of the Wegovy pill and ATTAIN-1 trial of Foundayo, New England Journal of Medicine
- CMS: Medicare GLP-1 Bridge
- Cash prices: NovoCare Wegovy home delivery and LillyDirect Foundayo, both checked November 22, 2026